Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme

Samalin, Ludovic; Rothärmel, Maud; Mékaoui, Lila; Gaudre-Wattinne, E.; Codet, M.A.; Bouju, Sophie; Sauvaget, Anne

doi:10.1080/13651501.2022.2030757

Public

Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme

Published in International Journal of Psychiatry in Clinical Practice • Feb 17, 2022

Authors:

Ludovic Samalin

Maud Rothärmel

Lila Mékaoui

Abstract

OBJECTIVE: To present the first real-world data of patients with treatment-resistant depression (TRD) treated with esketamine through a French cohort Temporary Authorisation for Use (ATUc) programme. METHODS: In 2019, the French Health Authorities exceptionally granted the first ATUc in psychiatry f...

Subject

Treatment-resistant depression

Cohort

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!